HYPEREOSINOPHILIC SYNDROME
Clinical trials for HYPEREOSINOPHILIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPEREOSINOPHILIC SYNDROME trials appear
Sign up with your email to follow new studies for HYPEREOSINOPHILIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental pill tested against seven rare blood diseases
Disease control CompletedThis study tested whether an oral medication called dasatinib could help control several rare blood cancers and disorders. Sixty-eight adults with conditions like acute myeloid leukemia, myelofibrosis, and mastocytosis took the pill daily for as long as it worked. Researchers mea…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug tested to tame rare blood disorder in kids
Disease control CompletedThis study tested whether a drug called mepolizumab, given as a shot under the skin, could help control a rare blood disorder called Hypereosinophilic Syndrome (HES) in children and teenagers aged 6 to 17. The main goal was to see if it could reduce the number of disease flare-up…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt for clues to spot rare blood disease
Knowledge-focused CompletedThis study aimed to find new, easier-to-use markers in the blood to help doctors diagnose hypereosinophilic syndrome (HES), a rare disorder where the body makes too many of a certain type of white blood cell. Researchers analyzed blood proteins from 41 people with HES to look for…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC